Staging means finding out how far colon cancer has spread in your body. Physicians group colon cancers into stages I (1) through IV (4), with stage I being the least advanced and stage IV being the ...

Add Yahoo as a preferred source to see more of our stories on Google. Five years ago, Tim Cannon, a cancer doctor in Virginia, saw that his colon cancer patients were getting younger and their cancer ...

The results of the phase 3 ATOMIC trial fired another volley in the ongoing debate over adjuvant vs neoadjuvant immunotherapy for patients with locally advanced colon cancer. But experts are divided ...

A Scandinavian clinical trial has revealed that low-dose aspirin can halve the risk of colon and rectal cancer recurrence in patients with specific genetic mutations. The research, involving over ...

Colorectal cancer is one of the leading causes of cancer-related deaths in the United States, and as the years pass, it’s clear that the degree of people under 50 that are being diagnosed with the ...

Colon cancer is a leading cause of cancer-related deaths. It typically begins as a small growth of tissue called a polyp in the lining of the colon or rectum. While not all polyps become cancerous, ...

Colon and rectal cancers, once largely confined to people in their 60s and 70s, are increasingly striking adults in their 40s, 30s and even 20s. The shift is so sharp that specialists now talk about a ...

Colon cancer is the second-deadliest cancer in the US, partly due to low screening rates. New and emerging screening tools, like blood and breath tests, may offer alternatives to in-office screenings.

Colonoscopy screenings are a highly effective measure for preventing colon cancer. A healthy lifestyle, including diet and exercise, can reduce risk but does not eliminate the need for screening.

Colon cancer is the third most prevalent form of cancer in the U.S., and while screening has helped detect and prevent colon cancer from spreading, major advancements in treating colon cancer have ...

Treatment with a GLP-1 receptor agonist (RA) may offer a survival advantage in patients with colon cancer and obesity. In a real-world analysis of nearly 7000 patients with colon cancer, those taking ...

You're currently following this author! Want to unfollow? Unsubscribe via the link in your email. Follow Hilary Brueck Every time Hilary publishes a story, you’ll get an alert straight to your inbox!